TY - JOUR
T1 - Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives
AU - Bauckneht, Matteo
AU - Ciccarese, Chiara
AU - Laudicella, Riccardo
AU - Mosillo, Claudia
AU - D'Amico, Francesca
AU - Anghelone, Annunziato
AU - Strusi, Alessandro
AU - Beccia, Viria
AU - Bracarda, Sergio
AU - Fornarini, Giuseppe
AU - Tortora, Giampaolo
AU - Iacovelli, Roberto
PY - 2024
Y1 - 2024
N2 - In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.
AB - In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.
KW - prostate cancer
KW - theranostic
KW - prostate cancer
KW - theranostic
UR - http://hdl.handle.net/10807/302017
U2 - 10.1016/j.ctrv.2024.102698
DO - 10.1016/j.ctrv.2024.102698
M3 - Article
SN - 0305-7372
VL - 124
SP - N/A-N/A
JO - Cancer Treatment Reviews
JF - Cancer Treatment Reviews
ER -
